EMA Prepares to Overhaul EudraVigilance Online Adverse Event Reporting Program

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency’s EudraVigilance system for monitoring drug side effects and adverse events is about to undergo an overhaul, and regulators are readying drugmakers and national authorities with a new change plan.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00